scholarly journals Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension

2021 ◽  
Author(s):  
Ann‐Kathrin Schäfer ◽  
Tim Kuczera ◽  
Rebecca Wurm‐Kuczera ◽  
Dieter Müller ◽  
Ellen Born ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Resistant Hypertension ◽  
Baroreflex Activation Therapy ◽  
Activation Therapy

New Hope for Resistant Hypertention

2012 ◽  
Vol 5 (1) ◽  
pp. 81-91
Author(s):  
Z Rahman ◽  
KK Karmaker ◽  
M Ahmed ◽  
M Aziz ◽  
S Chowdhury ◽  
...  
Keyword(s):  
Resistant Hypertension ◽  
Patient Adherence ◽  
Public Health Problem ◽  
Drug Regimen ◽  
Renal Sympathetic Denervation ◽  
Major Public Health Problem ◽  
Antihypertensive Medications ◽  
Baroreflex Activation Therapy ◽  
Activation Therapy ◽  
Increasing Trends

Hypertension is a major public health problem. Despite the increasing awareness of hypertension and its implications among patients and treating physicians, the prevalence of resistant hypertension    remains high.Resistant hypertension define as blood pressure that remains elevated above treatment goals despite administration of an optimal three drug regimen that include a diuretic1 The prevalence of resistant    hypertension is projected to increase, owing to the aging population and increasing trends in obesity, sleep apnea, and chronic kidney disease. It is estimated that at least 10% of all patients with hypertension are resistant to existing drugs. Management of resistant hypertension must begin with  a careful evaluation of the patient to confirm the diagnosis and exclude factors associated with “pseudo-resistance,” such as improper BP measurement technique, the white-coat effect, and poor patient adherence to life-style and/or antihypertensive medications. Despite the use of the appropriate dose and type of diuretic to overcome the management of resistant hypertension, we can’t achieve our goal. But there is at least two devices namely Baroreflex Activation Therapy and Catheter-based  renal sympathetic denervation make the new hope for the patient with resistant hypertension DOI: http://dx.doi.org/10.3329/cardio.v5i1.12278 Cardiovasc. j. 2012; 5(1): 81-91

scholarly journals Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New Developments

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Teba Alnima ◽  
Peter W. de Leeuw ◽  
Abraham A. Kroon
Keyword(s):  
Resistant Hypertension ◽  
First Generation ◽  
Systolic Heart Failure ◽  
Drug Resistant ◽  
New Developments ◽  
Baroreflex Activation Therapy ◽  
Beneficial Effects ◽  
The Past ◽  
Carotid Baroreflex ◽  
Activation Therapy

In the past few years, novel accomplishments have been obtained in carotid baroreflex activation therapy (BAT) for the treatment of resistant hypertension. In addition, this field is still evolving with promising results in the reduction of blood pressure and heart rate. This overview addresses the latest developments in BAT for the treatment of drug-resistant hypertension. Although not totally understood considering the working mechanisms of BAT, it appeared to be possible to achieve at least as much efficacy of single-sided as bilateral stimulation. Therefore unlike the first-generation Rheos system, the second-generation Barostimneooperates by unilateral baroreflex activation, using a completely different carotid electrode. Also significant improvements in several cardiac parameters have been shown by BAT in hypertensive patients, which set the basis for further research to evaluate BAT as a therapy for systolic heart failure. Yet important uncertainties need to be clarified to guarantee beneficial effects; hence not all participants seem to respond to BAT.

scholarly journals Baroreflex Activation Therapy and Resistant Hypertension

2012 ◽  
Vol 59 (5) ◽  
pp. 541 ◽  
Author(s):  
Costas Tsioufis ◽  
Dimitris Tsiachris ◽  
Vasilios Papademetriou ◽  
Christodoulos Stefanadis
Keyword(s):  
Resistant Hypertension ◽  
Baroreflex Activation Therapy ◽  
Activation Therapy

scholarly journals The place of intervention methods of treatment of patients with resistant hypertension in clinical practice

2018 ◽  
Vol 15 (1) ◽  
pp. 21-22
Author(s):  
R A Agaeva ◽  
N M Danilov ◽  
O V Sagaydak ◽  
I E Chazova
Keyword(s):  
Clinical Practice ◽  
Resistant Hypertension ◽  
Renal Denervation ◽  
High Technology ◽  
Scientific Interest ◽  
Arteriovenous Anastomosis ◽  
Baroreflex Activation Therapy ◽  
Activation Therapy ◽  
Methods Of Treatment

Every year scientific interest in studying of interventional methods of treatment of resistant hypertension steadily increases. Row of high technology device are created for performance of such procedures as well as techniques of their management are also developed. Non-pharmacological ways of treatment are described in this article, which are widely used in clinical practice: baroreflex activation therapy, radiofrequency renal denervation, and central iliac arteriovenous anastomosis.

Sign in / Sign up

Export Citation Format

Share Document